Tetraploidy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3305Q92.7
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tetraploidy syndrome is an extremely rare and severe chromosomal disorder in which cells contain four complete sets of chromosomes (92 chromosomes instead of the normal 46). This condition, also referred to as tetraploidy or 92,XXXX/92,XXYY karyotype, arises from errors in cell division during very early embryonic development. Tetraploidy may occur in a complete (pure) form or as a mosaic, where only some cells carry the tetraploid complement while others are normal. Complete tetraploidy is almost invariably lethal, with most affected pregnancies ending in early miscarriage or stillbirth. The rare liveborn infants with complete or mosaic tetraploidy typically present with severe multi-system abnormalities. Key clinical features include profound intrauterine growth restriction, severe intellectual disability, craniofacial anomalies (such as low-set ears, hypertelorism, micrognathia, and cleft palate), congenital heart defects, central nervous system malformations, skeletal anomalies, and genital abnormalities. Hypotonia and feeding difficulties are commonly observed in surviving neonates. Additional features may include renal malformations and limb defects. The phenotype can vary depending on whether the tetraploidy is complete or mosaic, with mosaic forms generally being less severe but still associated with significant developmental delays and congenital anomalies. There is no curative treatment for tetraploidy syndrome. Management is entirely supportive and symptomatic, focusing on addressing individual congenital anomalies such as surgical correction of heart defects or cleft palate, nutritional support, and developmental therapies. Prognosis is extremely poor for complete tetraploidy, with survival beyond the neonatal period being exceptionally rare. Mosaic tetraploidy may allow for somewhat longer survival, though significant morbidity remains. Genetic counseling is recommended for affected families, although the condition is generally considered a sporadic event with a very low recurrence risk.

Clinical phenotype terms— hover any for plain English:

Chiari malformationHP:0002308Radial ray deficiencyHP:0006433Biparietal narrowingHP:0004422Aplasia/Hypoplasia affecting the eyeHP:0008056Aplasia/Hypoplasia of the thymusHP:0010515Hypoplasia of the ear cartilageHP:0100720
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tetraploidy syndrome.

View clinical trials →

No actively recruiting trials found for Tetraploidy syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tetraploidy syndrome community →

No specialists are currently listed for Tetraploidy syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tetraploidy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tetraploidy syndromeForum →

No community posts yet. Be the first to share your experience with Tetraploidy syndrome.

Start the conversation →

Latest news about Tetraploidy syndrome

No recent news articles for Tetraploidy syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tetraploidy syndrome

What is Tetraploidy syndrome?

Tetraploidy syndrome is an extremely rare and severe chromosomal disorder in which cells contain four complete sets of chromosomes (92 chromosomes instead of the normal 46). This condition, also referred to as tetraploidy or 92,XXXX/92,XXYY karyotype, arises from errors in cell division during very early embryonic development. Tetraploidy may occur in a complete (pure) form or as a mosaic, where only some cells carry the tetraploid complement while others are normal. Complete tetraploidy is almost invariably lethal, with most affected pregnancies ending in early miscarriage or stillbirth. The

How is Tetraploidy syndrome inherited?

Tetraploidy syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tetraploidy syndrome typically begin?

Typical onset of Tetraploidy syndrome is neonatal. Age of onset can vary across affected individuals.